Used in biomedical research to quantify levels of human carbonic anhydrase in biological samples such as serum, plasma, and cell lysates. Widely applied in studies related to cancer, glaucoma, and metabolic disorders where CA isoforms serve as biomarkers. Enables high-throughput screening and evaluation of CA inhibitors in drug development. Supports diagnostic research by detecting abnormal CA expression linked to tumor progression and hypoxia-related conditions.